Efficacy and safety of vildagliptin, Saxagliptin or Sitagliptin as add-on therapy in Chinese patients with type 2 diabetes inadequately controlled with dual combination of traditional oral hypoglycemic agents
Crossref DOI link: https://doi.org/10.1186/1758-5996-6-69
Published Online: 2014-05-31
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Li, Chun-Jun
Liu, Xiao-Juan
Bai, Lian
Yu, Qian
Zhang, Qiu-Mei
Yu, Pei
Yu, De-Min
Article History
Received: 9 March 2014
Accepted: 26 May 2014
First Online: 31 May 2014